iRhythm Technologies Inc Cash Flow Conversion Efficiency

Latest as of March 2026: -0.162x

iRhythm Technologies Inc cash flow conversion efficiency. Based on the latest financial reports, iRhythm Technologies Inc (IRTC) has a cash flow conversion efficiency ratio of -0.162x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-26.17 Million) by net assets ($161.21 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of iRhythm Technologies Inc (2013–2025)

Cash flow conversion efficiency of iRhythm Technologies Inc from 2013 to 2025. This chart illustrates how iRhythm Technologies Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. View iRhythm Technologies Inc share price for real-time trading data and today's change.

iRhythm Technologies Inc Cash Flow Conversion Ratio Explained

iRhythm Technologies Inc cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

iRhythm Technologies Inc Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of iRhythm Technologies Inc ranked by their cash flow conversion efficiency. Also see IRTC stock market capitalisation for the company's overall valuation and market capitalisation.

Company Cash Flow Conversion Efficiency
G-bits Network Technology Xiamen Co Ltd
SHG:603444
0.133x
Thunder Software Technology Co Ltd
SHE:300496
0.017x
Stepstone Group Inc
NASDAQ:STEP
-0.369x
WSFS Financial Corporation
NASDAQ:WSFS
0.045x
Corporación Inmobiliaria Vesta S.A.B. de C.V
MX:VESTA
0.014x
Andon Health Co Ltd
SHE:002432
0.024x
Guangdong HongDa Blasting Co Ltd
SHE:002683
0.001x
Kesko Oyj
HE:KESKOA
0.135x

Annual Cash Flow Conversion Efficiency for iRhythm Technologies Inc (2013–2025)

The table below shows the annual cash flow conversion efficiency of iRhythm Technologies Inc from 2013 to 2025. Review IRTC free cash flow to operating cash ratio to assess how much free cash flow the company generates relative to operating cash flow.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-12-31 $152.75 Million $80.86 Million 0.529x +1319.65%
2024-12-31 $90.91 Million $3.39 Million 0.037x +115.64%
2023-12-31 $210.10 Million $-50.10 Million -0.238x -148.51%
2022-12-31 $239.81 Million $-23.01 Million -0.096x +28.95%
2021-12-31 $279.51 Million $-37.75 Million -0.135x -235.35%
2020-12-31 $341.61 Million $-13.76 Million -0.040x +75.05%
2019-12-31 $135.41 Million $-21.86 Million -0.161x +69.77%
2018-12-31 $54.42 Million $-29.07 Million -0.534x -184.96%
2017-12-31 $79.55 Million $-14.91 Million -0.187x -4.19%
2016-12-31 $92.56 Million $-16.65 Million -0.180x -201.53%
2015-12-31 $-101.62 Million $-18.00 Million 0.177x +108.24%
2014-12-31 $7.26 Million $-15.63 Million -2.151x +16.49%
2013-12-31 $4.60 Million $-11.85 Million -2.576x --

About iRhythm Technologies Inc

NASDAQ:IRTC USA Medical Devices
Market Cap
$4.15 Billion
Market Cap Rank
#4222 Global
#1497 in USA
Share Price
$126.37
Change (1 day)
+0.16%
52-Week Range
$101.79 - $189.25
All Time High
$268.46
About

iRhythm Holdings, Inc., a digital healthcare company, engages in the design, development, and commercialization of device-based technology that provides ambulatory cardiac monitoring services to diagnose arrhythmias in the United States. The company offers Zio ambulatory cardiac monitoring services, including long-term and short-term continuous monitoring and mobile cardiac telemetry monitoring s… Read more